In 2024, UAB Rx pharma had revenue of 24.7 million EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 24,7m € | 0 € | 0 € -100.0% |
Profit | - -100.0% | 516,5k € -65.5% | 1,5m € +105.4% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - -100.0% |
Employees | - | - | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB Rx pharma is located at Vilnius, Ukmergės g. 369A-101, LT-12142, LT-LT-12142.
The shareholders of UAB Rx pharma include 1 Lithuanian legal entities. View ownership details →
Yes, UAB Rx pharma is registered as an active VAT payer with VAT number LT100005567518.
UAB Rx pharma was founded on November 17, 2008. The company has been operating for 18 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 18 years | 74 - 78 | 59% | |
Net revenue | 24 666 210,00 € | 12 - 16 | 93% | |
Registered capital | 2896,00 € | - | 10% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.